Why am I experiencing mood changes, feeling grey and slightly depressed, after stopping a 200mg medication and reducing Abilify (aripiprazole) from 5mg to 2.5mg, while taking Lamictal (lamotrigine) 200mg, Zoloft (sertraline) 100mg, and Propranolol 20mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mood Changes After Abilify Dose Reduction

You are most likely experiencing withdrawal symptoms from reducing Abilify (aripiprazole) from 5mg to 2.5mg, potentially compounded by discontinuing the unspecified 200mg medication. This "grey" and depressed feeling is a recognized phenomenon when reducing or stopping aripiprazole, particularly when combined with other medication changes.

Why This Is Happening

Aripiprazole Discontinuation Effects

Reducing aripiprazole can cause a discontinuation syndrome characterized by mood changes, anxiety, and emotional blunting. 1 While aripiprazole discontinuation syndrome is less commonly discussed than with SSRIs, case reports document that stopping or reducing this medication can produce significant mood symptoms including the "grey" feeling you describe 1.

  • Aripiprazole has unique dopamine partial agonist properties that your brain has adapted to over time 2
  • When the dose is reduced, your dopamine system must readjust, which can temporarily cause mood dysregulation 2
  • The combination of aripiprazole with lamotrigine (your Lamictal) and antidepressants (your Zoloft) creates a complex neurochemical balance that is disrupted when one component changes 3

Compounding Factors

The simultaneous discontinuation of another 200mg medication (identity unknown) likely amplifies your mood symptoms through additive withdrawal effects. 4

  • If the discontinued medication was an SSRI like sertraline, discontinuation syndrome includes depression, fatigue, lethargy, and general malaise 4
  • Multiple medication changes occurring simultaneously create overlapping withdrawal phenomena that can intensify mood symptoms 4

Timeline Considerations

Withdrawal symptoms from dose reductions typically emerge within days and can persist for weeks, particularly with medications affecting dopamine and serotonin systems. 4, 1

  • Aripiprazole has a long half-life (approximately 75 hours), meaning full effects of dose reduction may not manifest for several days 5
  • Your current symptoms likely represent the peak withdrawal period 4

What You Should Do

Immediate Management

Contact your prescribing physician immediately to discuss your symptoms. 6 Do not make further medication changes without medical guidance.

  • Your prescriber needs to know about the emergence of depressive symptoms, as this may indicate the dose reduction was too rapid or too large 6
  • Consider whether returning to 5mg Abilify temporarily while implementing a slower taper schedule might be appropriate 3

Monitoring for Serious Symptoms

Watch carefully for worsening depression, suicidal thoughts, severe anxiety, or akathisia (inner restlessness), as these require urgent medical attention. 6, 3

  • The combination of aripiprazole with lamotrigine and sertraline has been specifically associated with increased anxiety and suicidal ideation during dose changes 3
  • Report immediately if you experience: severe agitation, panic attacks, marked insomnia, impulsivity, or thoughts of self-harm 6

Taper Strategy Going Forward

If continuing the dose reduction, a much slower taper with smaller decremental changes (e.g., 1mg reductions every 2-4 weeks) may minimize withdrawal symptoms. 4

  • Abrupt or large dose reductions are more likely to cause discontinuation symptoms than gradual tapers 4
  • Some patients require even slower tapers or may not tolerate dose reductions at all 3

Important Caveats

The "grey" feeling may also represent inadequate treatment of your underlying condition rather than pure withdrawal. 7 Your prescriber must distinguish between:

  • Withdrawal/discontinuation symptoms (temporary, related to medication change)
  • Re-emergence of underlying mood disorder symptoms (indicating the higher dose was necessary)
  • Inadequate overall treatment regimen requiring adjustment 7

Your current medication combination (lamotrigine, sertraline, low-dose aripiprazole, propranolol) suggests treatment for bipolar disorder or treatment-resistant depression. 3, 7 The 5mg to 2.5mg reduction may have dropped you below the therapeutic threshold for your condition, meaning the depression you feel could be breakthrough symptoms rather than withdrawal 7.

References

Research

An aripiprazole discontinuation syndrome.

Rhode Island medical journal (2013), 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Aripiprazole in the treatment of refractory mood disorders: a case series.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.